W STRATEGIES, LLC

Lobbying for IPSEN BIOPHARMACEUTICALS, INC. · Biopharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · $20,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Medicare/Medicaid

Monitored Public Law 119-21: One Big Beautiful Bill Act. Issues related to drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem